Page 60 - TD-2-2

Tumor Discovery Choroid plexus tumors: Benign to malignant

14(6): 1004–1012. aggressiveness. Clin Epigenetics, 11(1): 117.
https://doi.org/10.2174/1874467213666200730115837 https://doi.org/10.1186/S13148-019-0708-z/figures/8
165. de Menezes MR, Acioli MEA, da Trindade ACL, et al., 176. Merino DM, Shlien A, Villani A, et al., 2015, Molecular
2021, Potential role of microRNAs as biomarkers in human characterization of choroid plexus tumors reveals novel
glioblastoma: A mini systematic review from 2015 to 2020. clinically relevant subgroups. Clin Cancer Res, 21(1):
Mol Biol Rep, 48(5): 4647–4658. 184–192.
https://doi.org/10.1007/S11033-021-06423-9 https://doi.org/10.1158/1078-0432.CCR-14-1324
166. Beylerli O, Gareev I, Sufianov A, et al., 2022, The role 177. Chu BF, Karpenko MJ, Liu Z, et al., 2013, Phase I study of
of microRNA in the pathogenesis of glial brain tumors. 5-aza-2’-deoxycytidine in combination with valproic acid in
Noncoding RNA Res, 7(2): 71–76. non-small-cell lung cancer. Cancer Chemother Pharmacol,
71(1): 115–121.
https://doi.org/10.1016/j.ncrna.2022.02.005
https://doi.org/10.1007/S00280-012-1986-8
167. Von Eyss B, Maaskola J, Memczak S, et al., 2012, The SNF2-
like helicase HELLS mediates E2F3-dependent transcription 178. Akasaki Y, Kikuchi T, Homma S, et al., 2016, Phase I/II
and cellular transformation. EMBO J, 31(4): 972–985. trial of combination of temozolomide chemotherapy and
immunotherapy with fusions of dendritic and glioma cells
https://doi.org/10.1038/EMBOJ.2011.451
in patients with glioblastoma. Cancer Immunol Immunother,
168. Myant K, Termanis A, Sundaram AYM, et al., 2011, LSH 65(12): 1499–1509.
and G9a/GLP complex are required for developmentally https://doi.org/10.1007/S00262-016-1905-7/METRICS
programmed DNA methylation. Genome Res, 21(1): 83–94.
179. Zuckerman JE, Gritli I, Tolcher A, et al., 2014, Correlating
https://doi.org/10.1101/GR.108498.110
animal and human phase Ia/Ib clinical data with CALAA-
169. Zemach A, Kim MY, Hsieh PH, et al., 2013, The 01, a targeted, polymer-based nanoparticle containing
Arabidopsis nucleosome remodeler DDM1 allows siRNA. Proc Natl Acad Sci U S A, 111(31): 11449–11454.
DNA methyltransferases to access H1-containing
heterochromatin. Cell, 153(1): 193–205. https://doi.org/10.1073/PNAS.1411393111
180. Chaturvedi K, Ganguly K, Kulkarni AR, et al., 2011,
https://doi.org/10.1016/J.CELL.2013.02.033
Cyclodextrin-based siRNA delivery nanocarriers: A state-
170. Rickert CH, Wiestler OD, Paulus W, 2002, Chromosomal of-the-art review. Expert Opin Drug Deliv, 8(11): 1455–1468.
imbalances in choroid plexus tumors. Am J Pathol, https://doi.org/10.1517/17425247.2011.610790
160(3): 1105.
181. Unger C, Häring B, Medinger M, et al., 2007, Phase I
https://doi.org/10.1016/S0002-9440(10)64931-0
and pharmacokinetic study of the (6-maleimidocaproyl)
171. de Oliveira Garcia FA, Evangelista AF, Mançano BM, et al., hydrazone derivative of doxorubicin. Clin Cancer Res,
2023, Genomic profile of two Brazilian choroid plexus 13(16): 4858–4866.
tumors by whole-exome sequencing. Cold Spring Harb Mol https://doi.org/10.1158/1078-0432.CCR-06-2776
Case Stud, 9(1): a006245.
182. Liang C, Xu L, Song G, et al., 2016, Emerging nanomedicine
https://doi.org/10.1101/MCS.A006245
approaches fighting tumor metastasis: Animal models,
172. Thomas C, Soschinski P, Zwaig M, et al., 2021, The genetic metastasis-targeted drug delivery, phototherapy, and
landscape of choroid plexus tumors in children and adults. immunotherapy. Chem Soc Rev, 45(22): 6250–6269.
Neuro Oncol, 23(4): 650–660.
https://doi.org/10.1039/C6CS00458J
https://doi.org/10.1093/neuonc/noaa267
183. Liu H, Xu C, Meng M, et al., 2022, Metal-organic
173. Li Y, Liu H, Li T, et al., 2021, Choroid plexus carcinomas framework-mediated multifunctional nanoparticles for
with TP53 germline mutations: Management and outcome. combined chemo-photothermal therapy and enhanced
Front Oncol, 11: 751784. immunotherapy against colorectal cancer. Acta Biomater,
144: 132–141.
https://doi.org/10.3389/fonc.2021.751784/full
https://doi.org/10.1016/J.ACTBIO.2022.03.023
174. Thomas C, Metrock K, Kordes U, et al., 2020, Epigenetics
impacts upon prognosis and clinical management of choroid 184. Ou K, Xu X, Guan S, et al., 2020, Nanodrug carrier based
plexus tumors. J Neurooncol, 148(1): 39–45. on poly(Ursolic Acid) with self-anticancer activity against
colorectal cancer. Adv Funct Mater, 30(9): 1907857.
https://doi.org/10.1007/S11060-020-03509-5
https://doi.org/10.1002/adfm.201907857
175. Pienkowska M, Choufani S, Turinsky AL, et al., 2019, DNA
methylation signature is prognostic of choroid plexus tumor 185. Wang R, Yang Y, Yang M, et al., 2020, Synergistic inhibition

Volume 2 Issue 2 (2023) 18 https://doi.org/10.36922/td.1057